Biotechnology
Application of biological systems and organisms to develop products and technologies
Market Overview
Current Market Size
$850B (2024)
Projected Market Size
$1.2T (2030) (2024-2030)
Description
Synthetic biology, gene editing, biomanufacturing, precision medicine
Key Technology Segments
Synthetic Biology
Engineering biological systems for new functions
Gene Editing
CRISPR and other gene editing technologies
Biomanufacturing
Production of materials and chemicals using biological processes
Key Players
MIT
universityPioneering synthetic biology and gene editing research
Investment Trends
Investment in biotechnology has shown strong growth, with total funding reaching $42.1B in 2024.
Commercialization Pathways
Licensing
high feasibilityBiotech innovations often licensed to pharma companies for development and commercialization.
Spinout
high feasibilityStrong biotech startup ecosystem with significant investor interest and clear regulatory pathways.
Partnership
high feasibilityStrategic partnerships with pharma and biotech companies are common for early-stage technologies.
Regulatory Considerations
- •FDA approval processes
- •Clinical trial requirements
- •Biosafety regulations
- •Intellectual property protection
Frequently Asked Questions
What is the market size for biotechnology?
The biotechnology market is currently valued at $850B (2024) and is projected to reach $1.2T (2030) by 2030, representing a 15% CAGR growth rate.
What are the main commercialization pathways for biotechnology?
The primary commercialization pathways include licensing, spinout, partnership. Spinouts are particularly viable given strong investor interest.
Which universities are leading in biotechnology research?
Leading universities in biotechnology include MIT, Stanford, UC Berkeley, and others. These institutions have strong research programs and commercialization track records in this area.
What are the key technology segments in biotechnology?
Key technology segments include Synthetic Biology, Gene Editing, Biomanufacturing. These segments represent different areas of innovation and market opportunity within the broader biotechnology category.
Leading Universities
MIT
75 spinouts • $45.2M revenue
Stanford
110 spinouts • $95.0M revenue
UC Berkeley
125 spinouts • $52.3M revenue
Harvard
85 spinouts • $62.0M revenue
Johns Hopkins
78 spinouts • $55.0M revenue
Related Tools
Get Market Intelligence
Use Commercify to analyze market opportunities and build your commercialization strategy.
See plans & pricing